jag009
★★★

NJ,
2012-05-22 23:31
(5144 d 05:27 ago)

Posting: # 8607
Views: 3,769
 

 Adderall [Bioanalytics]

Hi Everyone,

As per FDA, BE studies for Mixed Amphetamine (Adderall, Adderall XR) requires measurement of both D- and L-amphetamine in the plasma. What about the requirement of 5% difference in relative potency (total Assay) between test and reference product? Does one have to demonstrate that on both D and L forms of amphetamine?

Thanks

John
drgunasakaran1
★★  
avatar

2012-05-31 16:34
(5135 d 12:24 ago)

@ jag009
Posting: # 8644
Views: 2,901
 

 Adderall

Dear Mr John,
The requirement of 5% difference in relative potency will be applicable for both D- and L-amphetamine.

Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
130 visitors (0 registered, 130 guests [including 21 identified bots]).
Forum time: 04:58 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5